Mr. John Drake, LLB
Mr. John Drake is the President and Founding Partner, Drake Goodwin Corporation in London, Ontario. Drake Goodwin Corporation is a London, Canada investment firm with diverse interests in financial services, real estate development and manufacturing. Drake Goodwin has realized substantial investment gains over the first 22 years of its history. Mr. Drake is Chairman of the DGM Bank & Trust Inc. of Barbados. Mr. Drake is also a director of Discovery Air Inc., a TSX Venture-listed company. Mr. Drake received his B.A. and LL.B. degrees from the University of Western Ontario.
Mr. J. Matthew Bond, CPA
Matt Bond brings more than 30 years of experience in finance and accounting. Most recently, Matt served as CFO for Bracket Global LLC, a clinical trial specialty services provider. Before that, he served as CFO for Aptiv Solutions, Inc and PRA International, Inc. Matt also spent more than a decade with Arthur Anderson, LLP. Matt holds a BS in Business from Wake Forest University and is also a Certified Public Accountant.
Ms. Alison Silva, MA
President and Chief Executive Officer
Alison Silva is the President, Chief Executive Officer and a Director of Cotinga Pharmaceuticals Inc. Previously, she was a co‐founder, Executive Vice President and Chief Operating Officer at Synlogic, Inc. where she lead the regulatory strategy, drug development, and operational aspects of the company’s focus on the discovery and development of engineered therapeutic probiotics. Alison is also a co‐founder of The Orphan Group, a specialty consulting company focused on assisting companies with developing and implementing their orphan drug strategy and product lifecycle management.
Alison previously held the position of Chief Operating Officer at SLA Pharma, a GI‐oncology focused biotech company, where she was responsible for heading up U.S. corporate and clinical operations for their pipeline of orphan drug candidates. Prior to joining SLA Pharma, Alison was Vice President of Drug Development at Marina Biotech through its acquisition of Cequent Pharmaceuticals in 2010, where she held the same role since 2007. Alison began her career in drug development in clinical operations with various positions at Pfizer, Massachusetts General Hospital, and the University of Massachusetts. Alison holds a Bachelor’s degree from Clark University and a Master’s degree from Clark University and UMass Medical Center.
Mr. Dave Sanderson, LLB
Dave is the co-founder and President of Red Jacket Capital Inc., a portfolio management and investment funds management company.
Prior to Red Jacket Capital, Dave was a Managing Director at BMO Nesbitt Burns where he managed one of the largest retail brokerage offices in Canada. This position was the most recent in a 15-year career in financial services during which he worked at another retail brokerage, TD Waterhouse, and in distribution at AIM Trimark Investments.
Dave is also an active private investor and co-founded Entertech Systems Inc. and Actual ID, companies that make biometric access, control and time and attendance technology and software. Mr. Sanderson is also a General Partner in a small venture fund that has investments in the medical device and security equipment industries.
Dave recently served on the Board of Directors of London Health Sciences Centre from 2009-2012 and the Fowler Kennedy Sports Injury Clinic from 2009-2012.
Dave has a business degree from The Richard Ivey School of Business at Western University and a law degree from Queen’s University. He was called to the Ontario Bar in 1992 and practiced at Stikeman, Elliott in Toronto for seven years as a corporate, commercial, and insolvency litigator.
Dr. John Yoo
Dr. Yoo is an oncologic and reconstructive surgeon specializing in cancers of the head and neck, thyroid and skin. He is Professor (and past Chairman and Department Chief) of Otolaryngology – Head and Neck Surgery and Professor of Oncology at Western University, and Co-Chair of the Head and Neck Disease Site for Cancer Care Ontario. Dr. Yoo was educated at the University of Toronto, where he completed his medical degree, surgical residency and advanced training in Head and Neck Cancer. He is a fellow of the American College of Surgeons and the Royal College of Surgeons of Canada.